Skip to main content
Erschienen in: Dysphagia 4/2014

01.08.2014 | Original Article

Swallowing Outcomes Following Unilateral STN vs. GPi Surgery: A Retrospective Analysis

verfasst von: Michelle S. Troche, Alexandra E. Brandimore, Kelly D. Foote, Takashi Morishita, Dennis Chen, Karen W. Hegland, Michael S. Okun

Erschienen in: Dysphagia | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

The adverse effects of deep brain stimulation (DBS) surgery on swallowing could potentially exacerbate the natural deterioration of airway protection associated with Parkinson’s disease (PD) degeneration and increase the incidence of aspiration pneumonia and associated death. There are no studies that compare swallowing outcomes associated with subthalamic nucleus (STN) versus globus pallidus interna (GPi) DBS surgery; therefore, we completed a retrospective study comparing swallowing outcomes in a cohort of patients with PD who underwent unilateral DBS surgery in either the STN or GPi. A chart review was completed to identify all patients with a diagnosis of PD who received videofluoroscopic swallowing evaluations before DBS and after unilateral DBS in the STN or GPi. The retrospective search yielded 33 patients (STN = 14, GPi = 19) with idiopathic PD who met the inclusion criteria. Mean penetration–aspiration (PA) scores did not change significantly for participants who underwent GPi surgery (z = –.181, p = .857), but mean PA scores significantly worsened for participants who underwent STN DBS (z = –2.682, p = .007). There was a significant improvement in Unified PD Rating Scale (UPDRS) scores off medication before surgery, to off medication and on stimulation after surgery for both groups (F = 23.667, p < .001). Despite the limitations of a retrospective analysis, this preliminary study suggests that unilateral STN DBS may have an adverse effect on swallowing function, while unilateral GPi DBS does not appear to have a similar deleterious effect. This study and other future studies should help to elucidate the mechanisms underpinning the effects of DBS on swallowing function.
Literatur
1.
Zurück zum Zitat Zahodne LB, Okun MS, Foote KD, Fernandez HH, Rodriguez RL, Kirsch-Darrow L, et al. Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinson’s disease: a controlled study using reliable change. Clin Neuropsychol. 2009;23:385–405.PubMedCentralPubMedCrossRef Zahodne LB, Okun MS, Foote KD, Fernandez HH, Rodriguez RL, Kirsch-Darrow L, et al. Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinson’s disease: a controlled study using reliable change. Clin Neuropsychol. 2009;23:385–405.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol. 2005;62:554–60.PubMedCrossRef Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol. 2005;62:554–60.PubMedCrossRef
3.
Zurück zum Zitat Okun MS, Gallo BV, Mandybur G, et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson’s disease: an open-label randomised controlled trial. Lancet Neurol. 2012;11:140–9.PubMedCrossRef Okun MS, Gallo BV, Mandybur G, et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson’s disease: an open-label randomised controlled trial. Lancet Neurol. 2012;11:140–9.PubMedCrossRef
4.
Zurück zum Zitat Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med. 2010;362:2077–91.PubMedCrossRef Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med. 2010;362:2077–91.PubMedCrossRef
5.
Zurück zum Zitat Hariz MI, Rehncrona S, Quinn NP, Speelman JD, Wensing C, et al. Multicenter study on deep brain stimulation in Parkinson’s disease: an independent assessment of reported adverse events at 4 years. Mov Disord. 2008;23:416–21.PubMedCrossRef Hariz MI, Rehncrona S, Quinn NP, Speelman JD, Wensing C, et al. Multicenter study on deep brain stimulation in Parkinson’s disease: an independent assessment of reported adverse events at 4 years. Mov Disord. 2008;23:416–21.PubMedCrossRef
6.
Zurück zum Zitat Rocchi L, Carlson-Kuhta P, Chiari L, Burchiel KJ, Hogarth P, Horak FB. Effects of deep brain stimulation in the subthalamic nucleus or globus pallidus internus on step initiation in Parkinson disease: laboratory investigation. J Neurosurg. 2012;117:1141–9.PubMedCentralPubMedCrossRef Rocchi L, Carlson-Kuhta P, Chiari L, Burchiel KJ, Hogarth P, Horak FB. Effects of deep brain stimulation in the subthalamic nucleus or globus pallidus internus on step initiation in Parkinson disease: laboratory investigation. J Neurosurg. 2012;117:1141–9.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Rodrigues JP, Walters SE, Watson P, Stell R, Mastaglia FL. Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson’s disease. Mov Disord. 2007;22:1866–70.PubMedCrossRef Rodrigues JP, Walters SE, Watson P, Stell R, Mastaglia FL. Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson’s disease. Mov Disord. 2007;22:1866–70.PubMedCrossRef
8.
Zurück zum Zitat Zahodne LB, Okun MS, Foote KD, Fernandez HH, Rodriguez RL, Wu SS, et al. Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus. J Neurol. 2009;256:1321–9.PubMedCentralPubMedCrossRef Zahodne LB, Okun MS, Foote KD, Fernandez HH, Rodriguez RL, Wu SS, et al. Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus. J Neurol. 2009;256:1321–9.PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Videnovic A, Metman LV. Deep brain stimulation for Parkinson’s disease: prevalence of adverse events and need for standardized reporting. Mov Disord. 2008;23:343–9.PubMedCrossRef Videnovic A, Metman LV. Deep brain stimulation for Parkinson’s disease: prevalence of adverse events and need for standardized reporting. Mov Disord. 2008;23:343–9.PubMedCrossRef
10.
Zurück zum Zitat Drapier D, Drapier S, Sauleau P, Haegelen C, Raoul S, Biseul I, et al. Does subthalamic nucleus stimulation induce apathy in Parkinson’s disease? J Neurol. 2006;253:1083–91.PubMedCrossRef Drapier D, Drapier S, Sauleau P, Haegelen C, Raoul S, Biseul I, et al. Does subthalamic nucleus stimulation induce apathy in Parkinson’s disease? J Neurol. 2006;253:1083–91.PubMedCrossRef
11.
Zurück zum Zitat Funkiewiez A, Ardouin C, Caputo E, Krack P, Fraix V, Klinger H, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson’s disease. J Neurol Neurosurg Psychiatr. 2004;75:834–9.PubMedCentralPubMedCrossRef Funkiewiez A, Ardouin C, Caputo E, Krack P, Fraix V, Klinger H, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson’s disease. J Neurol Neurosurg Psychiatr. 2004;75:834–9.PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Troche MS, Brandimore AE, Foote KD, Okun MS. Swallowing and deep brain stimulation in Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2013;19:783–8.PubMedCentralPubMedCrossRef Troche MS, Brandimore AE, Foote KD, Okun MS. Swallowing and deep brain stimulation in Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2013;19:783–8.PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Chung SJ, Jeon SR, Kim SR, Sung YH, Lee MC. Bilateral effects of unilateral subthalamic nucleus deep brain stimulation in advanced Parkinson’s disease. Eur Neurol. 2006;56:127–32.PubMedCrossRef Chung SJ, Jeon SR, Kim SR, Sung YH, Lee MC. Bilateral effects of unilateral subthalamic nucleus deep brain stimulation in advanced Parkinson’s disease. Eur Neurol. 2006;56:127–32.PubMedCrossRef
14.
Zurück zum Zitat Taba HA, Wu SS, Foote KD, Hass CJ, Fernandez HH, Malaty IA, et al. A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohort. J Neurosurg. 2010;113:1224–9.PubMedCrossRef Taba HA, Wu SS, Foote KD, Hass CJ, Fernandez HH, Malaty IA, et al. A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohort. J Neurosurg. 2010;113:1224–9.PubMedCrossRef
15.
Zurück zum Zitat Alberts JL, Hass CJ, Vitek JL, Okun MS. Are two leads always better than one: an emerging case for unilateral subthalamic deep brain stimulation in Parkinson’s disease. Exp Neurol. 2008;214:1–5.PubMedCentralPubMedCrossRef Alberts JL, Hass CJ, Vitek JL, Okun MS. Are two leads always better than one: an emerging case for unilateral subthalamic deep brain stimulation in Parkinson’s disease. Exp Neurol. 2008;214:1–5.PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood J. A penetration–aspiration scale. Dysphagia. 1996;11:93–8.PubMedCrossRef Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood J. A penetration–aspiration scale. Dysphagia. 1996;11:93–8.PubMedCrossRef
17.
Zurück zum Zitat McHorney CA, Robbins J, Lomax K, Rosenbek JC, Chignell K, Kramer AE, et al. The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity. Dysphagia. 2002;17:97–114.PubMedCrossRef McHorney CA, Robbins J, Lomax K, Rosenbek JC, Chignell K, Kramer AE, et al. The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity. Dysphagia. 2002;17:97–114.PubMedCrossRef
18.
Zurück zum Zitat Bronstein JM, Tagliati M, Alterman RL, Lozano AM, Volkmann J, Stefani A, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol. 2011;68:165.PubMedCrossRef Bronstein JM, Tagliati M, Alterman RL, Lozano AM, Volkmann J, Stefani A, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol. 2011;68:165.PubMedCrossRef
19.
Zurück zum Zitat Gorell JM, Johnson CC, Rybicki BA. Parkinson’s disease and its comorbid disorders: an analysis of Michigan mortality data, 1970 to 1990. Neurology. 1994;44:1865–8.PubMedCrossRef Gorell JM, Johnson CC, Rybicki BA. Parkinson’s disease and its comorbid disorders: an analysis of Michigan mortality data, 1970 to 1990. Neurology. 1994;44:1865–8.PubMedCrossRef
20.
Zurück zum Zitat Ciucci MR, Barkmeier-Kraemer JM, Sherman SJ. Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson’s disease. Mov Disord. 2008;23:676–83.PubMedCrossRef Ciucci MR, Barkmeier-Kraemer JM, Sherman SJ. Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson’s disease. Mov Disord. 2008;23:676–83.PubMedCrossRef
21.
Zurück zum Zitat Silbergleit AK, Lewitt P, Junn F, Schultz LR, Collins D, Beardsley T, et al. Comparison of dysphagia before and after deep brain stimulation in Parkinson’s disease. Mov Disord. 2012;27:1763–8.PubMedCrossRef Silbergleit AK, Lewitt P, Junn F, Schultz LR, Collins D, Beardsley T, et al. Comparison of dysphagia before and after deep brain stimulation in Parkinson’s disease. Mov Disord. 2012;27:1763–8.PubMedCrossRef
22.
Zurück zum Zitat Kulneff L, Sundstedt S, Olofsson K, van Doorn J, Linder J, Nordh E, et al. Deep brain stimulation—effects on swallowing function in Parkinson’s disease. Acta Neurol Scand. 2012;127:329–36.PubMedCrossRef Kulneff L, Sundstedt S, Olofsson K, van Doorn J, Linder J, Nordh E, et al. Deep brain stimulation—effects on swallowing function in Parkinson’s disease. Acta Neurol Scand. 2012;127:329–36.PubMedCrossRef
23.
Zurück zum Zitat Lengerer S, Kipping J, Rommel N, Weiss D, Breit S, Gasser T, et al. Deep-brain-stimulation does not impair deglutition in Parkinson’s disease. Parkinsonism Relat Disord. 2012;18:847–53.PubMedCrossRef Lengerer S, Kipping J, Rommel N, Weiss D, Breit S, Gasser T, et al. Deep-brain-stimulation does not impair deglutition in Parkinson’s disease. Parkinsonism Relat Disord. 2012;18:847–53.PubMedCrossRef
24.
Zurück zum Zitat Wolz M, Hauschild J, Fauser M, Klingelhofer L, Reichmann H, Storch A. Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson’s disease. Parkinsonism Relat Disord. 2012;18:994–7.PubMedCrossRef Wolz M, Hauschild J, Fauser M, Klingelhofer L, Reichmann H, Storch A. Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson’s disease. Parkinsonism Relat Disord. 2012;18:994–7.PubMedCrossRef
25.
Zurück zum Zitat Kitashima A, Umemoto G, Tsuboi Y, Higuchi MA, Baba Y, Kikuta T. Effects of subthalamic nucleus deep brain stimulation on the swallowing function of patients with Parkinson’s disease. Parkinsonism Relat Disord. 2013;19:480–2.PubMedCrossRef Kitashima A, Umemoto G, Tsuboi Y, Higuchi MA, Baba Y, Kikuta T. Effects of subthalamic nucleus deep brain stimulation on the swallowing function of patients with Parkinson’s disease. Parkinsonism Relat Disord. 2013;19:480–2.PubMedCrossRef
26.
Zurück zum Zitat Ramig LO, Fox C, Sapir S. Parkinson’s disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment. Semin Speech Lang. 2004;25:169–80.PubMedCrossRef Ramig LO, Fox C, Sapir S. Parkinson’s disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment. Semin Speech Lang. 2004;25:169–80.PubMedCrossRef
27.
Zurück zum Zitat Mena-Segovia J, Bolam JP, Magill PJ. Pedunculopontine nucleus and basal ganglia: distant relatives or part of the same family? Trends Neurosci. 2004;27:585–8.PubMedCrossRef Mena-Segovia J, Bolam JP, Magill PJ. Pedunculopontine nucleus and basal ganglia: distant relatives or part of the same family? Trends Neurosci. 2004;27:585–8.PubMedCrossRef
28.
Zurück zum Zitat Benarroch EE. Pedunculopontine nucleus: functional organization and clinical implications. Neurology. 2013;80:1148–55.PubMedCrossRef Benarroch EE. Pedunculopontine nucleus: functional organization and clinical implications. Neurology. 2013;80:1148–55.PubMedCrossRef
29.
Zurück zum Zitat Carpenter MB. Core text of neuroanatomy. 3rd ed. Baltimore: Williams & Wilkins; 1985. Carpenter MB. Core text of neuroanatomy. 3rd ed. Baltimore: Williams & Wilkins; 1985.
30.
Zurück zum Zitat St George RJ, Carlson-Kuhta P, Burchiel KJ, Hogarth P, Frank N, Horak FB. The effects of subthalamic and pallidal deep brain stimulation on postural responses in patients with Parkinson disease. J Neurosurg. 2012;116:1347–56.PubMedCentralPubMedCrossRef St George RJ, Carlson-Kuhta P, Burchiel KJ, Hogarth P, Frank N, Horak FB. The effects of subthalamic and pallidal deep brain stimulation on postural responses in patients with Parkinson disease. J Neurosurg. 2012;116:1347–56.PubMedCentralPubMedCrossRef
Metadaten
Titel
Swallowing Outcomes Following Unilateral STN vs. GPi Surgery: A Retrospective Analysis
verfasst von
Michelle S. Troche
Alexandra E. Brandimore
Kelly D. Foote
Takashi Morishita
Dennis Chen
Karen W. Hegland
Michael S. Okun
Publikationsdatum
01.08.2014
Verlag
Springer US
Erschienen in
Dysphagia / Ausgabe 4/2014
Print ISSN: 0179-051X
Elektronische ISSN: 1432-0460
DOI
https://doi.org/10.1007/s00455-014-9522-0

Weitere Artikel der Ausgabe 4/2014

Dysphagia 4/2014 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.